Herro
I believe that Neil Frazer in his Deutsche Bank presentation said that some of the patients treated with Cvac will relapse (get cancer). This aspect irelates to progression free survival time. Overall survival is the time a treated patient lives despite relapsing or being cancer free and is also important. So no need to worry about disease progression. They dont expect everyone treated with cvac to become cancer free forever and some will ofcourse relapse.
Somebody correct me if I am wrong.
Brainy
- Forums
- ASX - By Stock
- IMM
- 2b trial variation-safety profile assessment
2b trial variation-safety profile assessment, page-4
-
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMM (ASX) to my watchlist
|
|||||
Last
34.0¢ |
Change
0.005(1.49%) |
Mkt cap ! $493.8M |
Open | High | Low | Value | Volume |
33.5¢ | 34.0¢ | 33.0¢ | $1.220M | 3.642M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 57289 | 33.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
34.0¢ | 52306 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 36000 | 0.330 |
4 | 8311 | 0.325 |
4 | 86137 | 0.320 |
1 | 55000 | 0.315 |
3 | 48550 | 0.310 |
Price($) | Vol. | No. |
---|---|---|
0.345 | 39915 | 5 |
0.350 | 100659 | 8 |
0.355 | 130000 | 2 |
0.360 | 103645 | 4 |
0.365 | 161947 | 7 |
Last trade - 16.10pm 26/07/2024 (20 minute delay) ? |
Featured News
IMM (ASX) Chart |